Sio Gene Therapies Inc.
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize …
Biotechnology
US, New York [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Sio Gene Therapies Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDSio Gene Therapies Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Sio Gene Therapies Inc..
If you want to see a demo, head over to the financial segments of AAPL